AI pharmaceuticals and CRO concepts picked up in the afternoon. Berry Gene went up and down, breaking out of the 6-day 3-day market. Tenomaibo rose more than 10%, and Jinshi Asia Pharmaceutical, Insight Life, Nuochengjianhua, and Shenzhou Cell soared rapidly. According to the news, IsoMorphic Labs, an AI drug development startup, is advancing preliminary negotiations on a new round of financing. The valuation after this round of investment is at least 40 billion US dollars, and the maximum is expected to reach 50 billion US dollars.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.